Assistive Robotic in the Elderly: Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
Led by Istituto Nazionale di Ricovero e Cura per Anziani · Updated on 2023-10-23
195
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Parkinson's disease is a common cause of disability in older adults, characterized by motor problems including balance issues that do not improve with standard dopaminergic treatments. This research aims to explore new rehabilitation methods using robotic devices to enhance gait and reduce fall risk in elderly patients with Parkinson's disease. The study is a single-blinded randomized controlled trial involving 195 patients, designed to assess the effectiveness of these innovative approaches.
Participants will be randomly assigned to one of three groups: a control group receiving traditional rehabilitation therapy, a group using the Tymo system robotic device combined with traditional therapy, or a group using the Walker View robotic treadmill alongside traditional therapy. Each participant will complete 10 treatment sessions over 5 weeks, with two sessions per week. The control group will receive 50 minutes of traditional therapy per session, while the robotic groups will receive 30 minutes of traditional therapy plus 20 minutes with their assigned robotic device.
Throughout the study, patients will be evaluated at the start, after treatment, and during follow-ups at 6 months, 1 year, and 2 years to monitor outcomes such as fall risk, gait performance, and fear of falling. Assessments include task-oriented exercises using robotic platforms and traditional therapy, with long-term monitoring to understand sustained effects. This approach supports understanding how robotic rehabilitation may influence motor function and safety in elderly Parkinson's patients over time.
CONDITIONS
Brief Title
Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
Who Can Participate
Age: 65Years +
All Genders
Eligibility Criteria
You may qualify if you...
Parkinson's disease at stage 1 to 3 on the Hoen and Yahr scale
Functional Ambulation Classification (FAC) of 2 or less
Ranking scale score of 3 or less
Stable drug treatment for at least 1 month
Negative result on the 5-item Geriatric Depression Scale
You will not qualify if you...
Participation in other clinical studies
Lack of written informed consent
Clinical Dementia Rating (CDR) score of 3 or more
History of uncontrolled syncopal episodes, epilepsy, or vertigo
Serious autonomic system dysfunction
Severe behavioral syndromes not managed by medication
Other neurological diseases
Severe systemic diseases with life expectancy less than 1 year
Inability to complete follow-up assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 5 weeks
Participants receive rehabilitation treatment involving either traditional therapy or robotic-assisted therapy using the Tymo system or Walker View robotic treadmill.
2 visits per week for 5 weeks (total 10 sessions)
Follow-up
Duration - 2 years
Participants are assessed to evaluate the long-term effects of the rehabilitation treatment on gait, balance, and risk of falling.
Assessments at 6 months, 1 year, and 2 years after treatment
The Effect of Non-Immersive Virtual Reality Exergames versus Traditional Physiotherapy in Parkinson's Disease Older Patients: Preliminary Results from a Randomized-Controlled Trial.